Literature DB >> 29055119

Deep brain stimulation of the nucleus basalis of Meynert attenuates early EEG components associated with defective sensory gating in patients with Alzheimer disease - a two-case study.

Stefan Dürschmid1,2, Christoph Reichert1, Jens Kuhn3,4, Hans-Joachim Freund, Hermann Hinrichs1,2,5,6,7, Hans-Jochen Heinze1,2,5,6,7.   

Abstract

Alzheimer's disease (AD) is associated with deterioration of memory and cognitive function and a degeneration of neurons of the nucleus basalis of Meynert (NBM). The NBM is the major input source of acetylcholine (ACh) to the cortex. The decreasing cholinergic innervation of the cortex due to degeneration of the NBM might be the cause of loss of memory function. NBM-Deep brain stimulation (NBM-DBS) is considered to serve as a potential therapeutic option for patients with AD by supporting residual cholinergic transmission to stabilize oscillatory activity in memory-relevant circuits. However, whether DBS could improve sensory memory functions in patients with AD is not clear. Here, in a passive auditory oddball paradigm, patients with AD (N = 2) listened to repetitive background tones (standard tones) randomly interrupted by frequency deviants in two blocks with NBM-DBS OFF and then NBM-DBS ON, while age-matched healthy controls (N = 6) repeated the experiment twice. The mismatch negativity in NBM-DBS OFF significantly differed from controls in both blocks, but not under NBM-DBS, which was likely due to a pronounced P50 increase overlapping with the N1 in NBM-DBS OFF. This early complex of EEG components recovered under stimulation to a normal level as defined by responses in controls. In this temporal interval, we found in patients with NBM-DBS ON (but not with NBM-DBS OFF) and in controls a strong repetition suppression effect to standard tones - with more attenuated responses to frequently repeated standard tones. This highlights the role of NBM-DBS for sensory gating of familiar auditory information into sensory memory.
© 2017 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer disease; deep brain stimulation; mismatch negativity; nucleus basalis of Meynert

Mesh:

Year:  2017        PMID: 29055119     DOI: 10.1111/ejn.13749

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  6 in total

Review 1.  Basal Forebrain Impairment: Understanding the Mnemonic Function of the Septal Region Translates in Therapeutic Advances.

Authors:  Marian Tsanov
Journal:  Front Neural Circuits       Date:  2022-05-31       Impact factor: 3.342

Review 2.  Mechanisms for Cognitive Impairment in Epilepsy: Moving Beyond Seizures.

Authors:  Mohamed R Khalife; Rod C Scott; Amanda E Hernan
Journal:  Front Neurol       Date:  2022-05-12       Impact factor: 4.086

3.  Electrical stimulation of the nucleus basalis of meynert: a systematic review of preclinical and clinical data.

Authors:  Muhammad Nazmuddin; Ingrid H C H M Philippens; Teus van Laar
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

4.  Directional DBS of the Fornix in Alzheimer's Disease Achieves Long-Term Benefits: A Case Report.

Authors:  Juan A Barcia; María Aurora Viloria; Raquel Yubero; Leyre Sanchez-Sanchez-Rojas; Amanda López; Bryan Andrew Strange; María Cabrera; Leonides Canuet; Pedro Gil; Cristina Nombela
Journal:  Front Aging Neurosci       Date:  2022-04-01       Impact factor: 5.750

5.  Partial improvement in performance of patients with severe Alzheimer's disease at an early stage of fornix deep brain stimulation.

Authors:  Zhi-Qi Mao; Xin Wang; Xin Xu; Zhi-Qiang Cui; Long-Sheng Pan; Xiao-Jing Ning; Bai-Xuan Xu; Lin Ma; Zhi-Pei Ling; Jian-Jun Jia; Xin-Guang Yu
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

Review 6.  Deep Brain Stimulation: A Potential Treatment for Dementia in Alzheimer's Disease (AD) and Parkinson's Disease Dementia (PDD).

Authors:  Qing Lv; Ailian Du; Wenshi Wei; Yuanyuan Li; Gailing Liu; Xiao Ping Wang
Journal:  Front Neurosci       Date:  2018-05-29       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.